Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial

BACKGROUND: Xingnaojing injection (XNJ) is widely used for the treatment of stroke in China. However, there is currently a lack of high-quality evidence of its efficacy for acute ischemic stroke. The main objective of this study is to determine whether the addition of XNJ to standard care improves t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Xinxing, Cao, Kegang, Kong, Lingbo, Liu, Qiang, Gao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644245/
https://www.ncbi.nlm.nih.gov/pubmed/29037226
http://dx.doi.org/10.1186/s13063-017-2222-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644245/
https://www.ncbi.nlm.nih.gov/pubmed/29037226
http://dx.doi.org/10.1186/s13063-017-2222-y

Ejemplares similares